Search research articles
Contact Us
Filters
Showing results (231-240 of 308) with videos related to
Page
of 31
Sort By:
Vaccines
|
August 26, 2022
Improved SARS-CoV-2 Neutralization of Delta and Omicron BA.1 Variants of Concern after Fourth Vaccination in Hemodialysis Patients
Cho-Chin Cheng, Louise Platen, Catharina Christa, et al.
Nature Microbiology
|
July 30, 2025
Multi-proteomic profiling of the varicella-zoster virus-host interface reveals host susceptibilities to severe infection
Virginie Girault, Alexey Stukalov, Madalina Elena Carter-Timofte, et al.
Vaccines
|
March 28, 2024
SARS-CoV-2 Neutralization Capacity in Hemodialysis Patients with and without a Fifth Vaccination with the Updated Comirnaty Original/Omicron BA.4-5 Vaccine
Bo-Hung Liao, Louise Platen, Myriam Grommes, et al.
Frontiers in Immunology
|
April 17, 2023
Comparable cellular and humoral immunity upon homologous and heterologous COVID-19 vaccination regimens in kidney transplant recipients
Nina Körber, Christopher Holzmann-Littig, Gesa Wilkens, et al.
Nature Immunology
|
April 16, 2013
Intrahepatic myeloid-cell aggregates enable local proliferation of CD8(+) T cells and successful immunotherapy against chronic viral liver infection
Li-Rung Huang, Dirk Wohlleber, Florian Reisinger, et al.
Scientific Reports
|
November 4, 2020
Author Correction: Hypoxic gene expression in chronic hepatitis B virus infected patients is not observed in state-of-the-art in vitro and mouse infection models
Peter Jianrui Liu, James M Harris, Emanuele Marchi, et al.
Cell Reports. Medicine
|
September 1, 2021
Targeted T cell receptor gene editing provides predictable T cell product function for immunotherapy
Thomas R Müller, Sebastian Jarosch, Monika Hammel, et al.
Science Translational Medicine
|
June 27, 2014
HCV-induced immune responses influence the development of operational tolerance after liver transplantation in humans
Felix Bohne, María-Carlota Londoño, Carlos Benítez, et al.
Scientific Reports
|
August 26, 2020
Hypoxic gene expression in chronic hepatitis B virus infected patients is not observed in state-of-the-art in vitro and mouse infection models
Peter Jianrui Liu, James M Harris, Emanuele Marchi, et al.
Molecular Therapy. Nucleic Acids
|
August 13, 2025
MVA-HBVac-A novel vaccine vector that allows pan-genotypic targeting of hepatitis B virus by therapeutic vaccination
Anna D Kosinska, Martin Kächele, Helene A Kerth, et al.
Page
of 31
Search research articles
Search
Showing results (231-240 of 308) with videos related to
Sort By:
Page
of 31
Vaccines
|
August 26, 2022
Improved SARS-CoV-2 Neutralization of Delta and Omicron BA.1 Variants of Concern after Fourth Vaccination in Hemodialysis Patients
Cho-Chin Cheng, Louise Platen, Catharina Christa, et al.
Nature Microbiology
|
July 30, 2025
Multi-proteomic profiling of the varicella-zoster virus-host interface reveals host susceptibilities to severe infection
Virginie Girault, Alexey Stukalov, Madalina Elena Carter-Timofte, et al.
Vaccines
|
March 28, 2024
SARS-CoV-2 Neutralization Capacity in Hemodialysis Patients with and without a Fifth Vaccination with the Updated Comirnaty Original/Omicron BA.4-5 Vaccine
Bo-Hung Liao, Louise Platen, Myriam Grommes, et al.
Frontiers in Immunology
|
April 17, 2023
Comparable cellular and humoral immunity upon homologous and heterologous COVID-19 vaccination regimens in kidney transplant recipients
Nina Körber, Christopher Holzmann-Littig, Gesa Wilkens, et al.
Nature Immunology
|
April 16, 2013
Intrahepatic myeloid-cell aggregates enable local proliferation of CD8(+) T cells and successful immunotherapy against chronic viral liver infection
Li-Rung Huang, Dirk Wohlleber, Florian Reisinger, et al.
Scientific Reports
|
November 4, 2020
Author Correction: Hypoxic gene expression in chronic hepatitis B virus infected patients is not observed in state-of-the-art in vitro and mouse infection models
Peter Jianrui Liu, James M Harris, Emanuele Marchi, et al.
Cell Reports. Medicine
|
September 1, 2021
Targeted T cell receptor gene editing provides predictable T cell product function for immunotherapy
Thomas R Müller, Sebastian Jarosch, Monika Hammel, et al.
Science Translational Medicine
|
June 27, 2014
HCV-induced immune responses influence the development of operational tolerance after liver transplantation in humans
Felix Bohne, María-Carlota Londoño, Carlos Benítez, et al.
Scientific Reports
|
August 26, 2020
Hypoxic gene expression in chronic hepatitis B virus infected patients is not observed in state-of-the-art in vitro and mouse infection models
Peter Jianrui Liu, James M Harris, Emanuele Marchi, et al.
Molecular Therapy. Nucleic Acids
|
August 13, 2025
MVA-HBVac-A novel vaccine vector that allows pan-genotypic targeting of hepatitis B virus by therapeutic vaccination
Anna D Kosinska, Martin Kächele, Helene A Kerth, et al.
Page
of 31